A citation-based method for searching scientific literature


List of co-cited articles
articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Exome sequencing reveals a high prevalence of BRCA1 and BRCA2 founder variants in a diverse population-based biobank.
Noura S Abul-Husn, Emily R Soper, Jacqueline A Odgis, Sinead Cullina, Dean Bobo, Arden Moscati, Jessica E Rodriguez, Ruth J F Loos, Judy H Cho, Gillian M Belbin,[...]. Genome Med 2019
21
33

A high prevalence of BRCA1 mutations among breast cancer patients from the Bahamas.
Talia Donenberg, John Lunn, Duvaughn Curling, Theodore Turnquest, Elisa Krill-Jackson, Robert Royer, Steven A Narod, Judith Hurley. Breast Cancer Res Treat 2011
52
33

Associations among ancestry, geography and breast cancer incidence, mortality, and survival in Trinidad and Tobago.
Wayne A Warner, Robert L Morrison, Tammy Y Lee, Tanisha M Williams, Shelina Ramnarine, Veronica Roach, Simeon Slovacek, Ravi Maharaj, Nigel Bascombe, Melissa L Bondy,[...]. Cancer Med 2015
13
33

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.
Freddie Bray, Jacques Ferlay, Isabelle Soerjomataram, Rebecca L Siegel, Lindsey A Torre, Ahmedin Jemal. CA Cancer J Clin 2018
33


BRCA somatic mutations and epigenetic BRCA modifications in serous ovarian cancer.
M Moschetta, A George, S B Kaye, S Banerjee. Ann Oncol 2016
84
33

Prevalence and predictors of BRCA1 and BRCA2 mutations in a population-based study of breast cancer in white and black American women ages 35 to 64 years.
Kathleen E Malone, Janet R Daling, David R Doody, Li Hsu, Leslie Bernstein, Ralph J Coates, Polly A Marchbanks, Michael S Simon, Jill A McDonald, Sandra A Norman,[...]. Cancer Res 2006
204
33

Genetic Testing and Results in a Population-Based Cohort of Breast Cancer Patients and Ovarian Cancer Patients.
Allison W Kurian, Kevin C Ward, Nadia Howlader, Dennis Deapen, Ann S Hamilton, Angela Mariotto, Daniel Miller, Lynne S Penberthy, Steven J Katz. J Clin Oncol 2019
90
33

Multi-Gene Panel Testing of 23,179 Individuals for Hereditary Cancer Risk Identifies Pathogenic Variant Carriers Missed by Current Genetic Testing Guidelines.
Cynthia L Neben, Anjali D Zimmer, Will Stedden, Jeroen van den Akker, Robert O'Connor, Raymond C Chan, Elaine Chen, Zheng Tan, Annette Leon, Jack Ji,[...]. J Mol Diagn 2019
32
33

Breast Cancer, Version 3.2020, NCCN Clinical Practice Guidelines in Oncology.
William J Gradishar, Benjamin O Anderson, Jame Abraham, Rebecca Aft, Doreen Agnese, Kimberly H Allison, Sarah L Blair, Harold J Burstein, Chau Dang, Anthony D Elias,[...]. J Natl Compr Canc Netw 2020
128
33

Racial disparities in BRCA testing and cancer risk management across a population-based sample of young breast cancer survivors.
Deborah Cragun, Anne Weidner, Courtney Lewis, Devon Bonner, Jongphil Kim, Susan T Vadaparampil, Tuya Pal. Cancer 2017
82
33

Association of RAD51C germline mutations with breast cancer among Bahamians.
Maryam Bagherzadeh, Agata Szymiczek, Talia Donenberg, Raleigh Butler, Judith Hurley, Steven A Narod, Mohammad R Akbari. Breast Cancer Res Treat 2020
1
100

Lynch Syndrome-Associated Variants and Cancer Rates in an Ancestrally Diverse Biobank.
Rachel E Rosenblum, Celina Ang, Sabrina A Suckiel, Emily R Soper, Meenakshi R Sigireddi, Sinead Cullina, Gillian M Belbin, Aimee L Lucas, Eimear E Kenny, Noura S Abul-Husn. JCO Precis Oncol 2020
1
100

Cascading After Peridiagnostic Cancer Genetic Testing: An Alternative to Population-Based Screening.
Kenneth Offit, Kaitlyn A Tkachuk, Zsofia K Stadler, Michael F Walsh, Hector Diaz-Zabala, Jeffrey D Levin, Zoe Steinsnyder, Vignesh Ravichandran, Ravi N Sharaf, Melissa K Frey,[...]. J Clin Oncol 2020
12
33

Pressing Need to Dig Deeper Into Female Cancer Health Disparities.
Matthew Schlumbrecht, Camille Ragin, Laura Kohn-Wood, Sophia George. J Clin Oncol 2019
4
33

Inherited Breast Cancer in Nigerian Women.
Yonglan Zheng, Tom Walsh, Suleyman Gulsuner, Silvia Casadei, Ming K Lee, Temidayo O Ogundiran, Adeyinka Ademola, Adeyinka G Falusi, Clement A Adebamowo, Abideen O Oluwasola,[...]. J Clin Oncol 2018
35
33

Breast Cancer Screening for Women at Average Risk: 2015 Guideline Update From the American Cancer Society.
Kevin C Oeffinger, Elizabeth T H Fontham, Ruth Etzioni, Abbe Herzig, James S Michaelson, Ya-Chen Tina Shih, Louise C Walter, Timothy R Church, Christopher R Flowers, Samuel J LaMonte,[...]. JAMA 2015
698
33

Prevalence of founder mutations in the BRCA1 and BRCA2 genes among unaffected women from the Bahamas.
M Trottier, J Lunn, R Butler, D Curling, T Turnquest, W Francis, D Halliday, R Royer, S Zhang, S Li,[...]. Clin Genet 2016
14
33

A high frequency of BRCA mutations in young black women with breast cancer residing in Florida.
Tuya Pal, Devon Bonner, Deborah Cragun, Alvaro N A Monteiro, Catherine Phelan, Lily Servais, Jongphil Kim, Steven A Narod, Mohammad R Akbari, Susan T Vadaparampil. Cancer 2015
50
33

High triple-negative breast cancer prevalence and aggressive prognostic factors in Barbadian women with breast cancer.
Shawn M Hercules, Jevon C Hercules, Amna Ansari, Stephanie A J Date, Desiree H A Skeete, Suzanne P Smith Connell, Gregory R Pond, Juliet M Daniel. Cancer 2020
4
33

Prevalence of Variant Reclassification Following Hereditary Cancer Genetic Testing.
Jacqueline Mersch, Nichole Brown, Sara Pirzadeh-Miller, Erin Mundt, Hannah C Cox, Krystal Brown, Melissa Aston, Lisa Esterling, Susan Manley, Theodora Ross. JAMA 2018
76
33

The spectrum of BRCA1 and BRCA2 mutations in breast cancer patients in the Bahamas.
M R Akbari, T Donenberg, J Lunn, D Curling, T Turnquest, E Krill-Jackson, S Zhang, S A Narod, J Hurley. Clin Genet 2014
39
33

Cancer incidence and mortality rates and trends in Trinidad and Tobago.
Wayne A Warner, Tammy Y Lee, Kimberly Badal, Tanisha M Williams, Smriti Bajracharya, Vasavi Sundaram, Nigel A Bascombe, Ravi Maharaj, Marjorie Lamont-Greene, Allana Roach,[...]. BMC Cancer 2018
9
33

Leading Causes of Cancer Mortality - Caribbean Region, 2003-2013.
Hilda Razzaghi, Sarah Quesnel-Crooks, Recinda Sherman, Rachael Joseph, Betsy Kohler, Glennis Andall-Brereton, Marsha A Ivey, Brenda K Edwards, Les Mery, Vilma Gawryszewski,[...]. MMWR Morb Mortal Wkly Rep 2016
39
33

Racial/ethnic differences in multiple-gene sequencing results for hereditary cancer risk.
Jennifer L Caswell-Jin, Tanya Gupta, Evan Hall, Iva M Petrovchich, Meredith A Mills, Kerry E Kingham, Rachel Koff, Nicolette M Chun, Peter Levonian, Alexandra P Lebensohn,[...]. Genet Med 2018
54
33

Prevalence of Inherited Mutations in Breast Cancer Predisposition Genes among Women in Uganda and Cameroon.
Babatunde Adedokun, Yonglan Zheng, Paul Ndom, Antony Gakwaya, Timothy Makumbi, Alicia Y Zhou, Toshio F Yoshimatsu, Alex Rodriguez, Ravi K Madduri, Ian T Foster,[...]. Cancer Epidemiol Biomarkers Prev 2020
10
33

Identifying disparities in germline and somatic testing for ovarian cancer.
Marilyn Huang, Priyanka Kamath, Matthew Schlumbrecht, Feng Miao, Devin Driscoll, Sean Oldak, Brian Slomovitz, Tulay Koru-Sengul, Sophia George. Gynecol Oncol 2019
6
33

STrengthening the REporting of Genetic Association Studies (STREGA): an extension of the STROBE statement.
Julian Little, Julian P T Higgins, John P A Ioannidis, David Moher, France Gagnon, Erik von Elm, Muin J Khoury, Barbara Cohen, George Davey-Smith, Jeremy Grimshaw,[...]. PLoS Med 2009
232
33

Breast Cancer Research in the Caribbean: Analysis of Reports From 1975 to 2017.
Camille Ragin, Rishika Banydeen, Christine Zhang, Athena Ben, Victoria Calabrese, Nina N Villa, Jade Reville, Shaoni Dasgupta, Mausumi Bandyopadhyay, Delroy Louden,[...]. J Glob Oncol 2018
10
33

Strategies for recruitment of relatives of BRCA mutation carriers to a genetic testing program in the Bahamas.
M Trottier, J Lunn, R Butler, D Curling, T Turnquest, R Royer, M R Akbari, T Donenberg, J Hurley, S A Narod. Clin Genet 2015
11
33

Evaluation of a Streamlined Oncologist-Led BRCA Mutation Testing and Counseling Model for Patients With Ovarian Cancer.
Nicoletta Colombo, Gloria Huang, Giovanni Scambia, Eva Chalas, Sandro Pignata, James Fiorica, Linda Van Le, Sharad Ghamande, Santiago González-Santiago, Isabel Bover,[...]. J Clin Oncol 2018
46
33

Cancer Risks Associated With Germline PALB2 Pathogenic Variants: An International Study of 524 Families.
Xin Yang, Goska Leslie, Alicja Doroszuk, Sandra Schneider, Jamie Allen, Brennan Decker, Alison M Dunning, James Redman, James Scarth, Inga Plaskocinska,[...]. J Clin Oncol 2020
77
33

Multi-gene panel testing for hereditary cancer predisposition in unsolved high-risk breast and ovarian cancer patients.
Beth Crawford, Sophie B Adams, Taylor Sittler, Jeroen van den Akker, Salina Chan, Ofri Leitner, Lauren Ryan, Elad Gil, Laura van 't Veer. Breast Cancer Res Treat 2017
47
33

A systematic genetic assessment of 1,433 sequence variants of unknown clinical significance in the BRCA1 and BRCA2 breast cancer-predisposition genes.
Douglas F Easton, Amie M Deffenbaugh, Dmitry Pruss, Cynthia Frye, Richard J Wenstrup, Kristina Allen-Brady, Sean V Tavtigian, Alvaro N A Monteiro, Edwin S Iversen, Fergus J Couch,[...]. Am J Hum Genet 2007
309
33

Inherited predisposition to breast cancer among African American women.
Jane E Churpek, Tom Walsh, Yonglan Zheng, Zakiya Moton, Anne M Thornton, Ming K Lee, Silvia Casadei, Amanda Watts, Barbara Neistadt, Matthew M Churpek,[...]. Breast Cancer Res Treat 2015
82
33

Missed opportunities: Genetic counseling and testing among an ethnically diverse cohort of women with endometrial cancer.
Jessica Lee, Lindsay R Gubernick, Allison L Brodsky, Julia E Fehniger, Douglas A Levine, Deanna Gerber, Shabnam A Asgari, Anna Cantor, Jessica T Martineau, Ophira M Ginsburg,[...]. Gynecol Oncol 2018
12
33

Impact of an immunohistochemistry-based universal screening protocol for Lynch syndrome in endometrial cancer on genetic counseling and testing.
Antonina I Frolova, Sheri A Babb, Emily Zantow, Andrea R Hagemann, Matthew A Powell, Premal H Thaker, Feng Gao, David G Mutch. Gynecol Oncol 2015
29
33

Comprehensive population-wide analysis of Lynch syndrome in Iceland reveals founder mutations in MSH6 and PMS2.
Sigurdis Haraldsdottir, Thorunn Rafnar, Wendy L Frankel, Sylvia Einarsdottir, Asgeir Sigurdsson, Heather Hampel, Petur Snaebjornsson, Gisli Masson, Daniel Weng, Reynir Arngrimsson,[...]. Nat Commun 2017
46
33

The proportion of endometrial cancers associated with Lynch syndrome: a systematic review of the literature and meta-analysis.
N A J Ryan, M A Glaire, D Blake, M Cabrera-Dandy, D G Evans, E J Crosbie. Genet Med 2019
46
33

Hereditary colon cancer: lynch syndrome.
Eunjeong Jang, Daniel C Chung. Gut Liver 2010
21
33

Mutation analysis of the MLH1, MSH2 and MSH6 genes in patients with double primary cancers of the colorectum and the endometrium: a population-based study in northern Sweden.
Kristina Cederquist, Monica Emanuelsson, Ingela Göransson, Elke Holinski-Feder, Yvonne Müller-Koch, Irina Golovleva, Henrik Grönberg. Int J Cancer 2004
30
33


Molecular analysis of familial endometrial carcinoma: a manifestation of hereditary nonpolyposis colorectal cancer or a separate syndrome?
Miina Ollikainen, Wael M Abdel-Rahman, Anu-Liisa Moisio, Annette Lindroos, Reetta Kariola, Irma Järvelä, Minna Pöyhönen, Ralf Butzow, Päivi Peltomäki. J Clin Oncol 2005
97
33

MLH1 and MSH2 protein expression as a pre-screening marker in hereditary and non-hereditary endometrial hyperplasia and cancer.
M J Berends, H Hollema, Y Wu, T van Der Sluis, R G Mensink, K A ten Hoor, R H Sijmons, E G de Vries, E Pras, M J Mourits,[...]. Int J Cancer 2001
57
33

Do MSH6 mutations contribute to double primary cancers of the colorectum and endometrium?
G S Charames, A L Millar, T Pal, S Narod, B Bapat. Hum Genet 2000
37
33

Toward new strategies to select young endometrial cancer patients for mismatch repair gene mutation analysis.
Maran J W Berends, Ying Wu, Rolf H Sijmons, Tineke van der Sluis, Wietske Boersmavan Ek, Marjolijn J L Ligtenberg, Neeltje J W Arts, Klaske A ten Hoor, Jan H Kleibeuker, Elisabeth G E de Vries,[...]. J Clin Oncol 2003
94
33

Multi-disciplinary summit on genetics services for women with gynecologic cancers: A Society of Gynecologic Oncology White Paper.
Leslie M Randall, Bhavana Pothuri, Elizabeth M Swisher, John P Diaz, Adam Buchanan, Catherine T Witkop, C Bethan Powell, Ellen Blair Smith, Mark E Robson, Jeff Boyd,[...]. Gynecol Oncol 2017
52
33

Efficacy of Pembrolizumab in Patients With Noncolorectal High Microsatellite Instability/Mismatch Repair-Deficient Cancer: Results From the Phase II KEYNOTE-158 Study.
Aurelien Marabelle, Dung T Le, Paolo A Ascierto, Anna Maria Di Giacomo, Ana De Jesus-Acosta, Jean-Pierre Delord, Ravit Geva, Maya Gottfried, Nicolas Penel, Aaron R Hansen,[...]. J Clin Oncol 2020
383
33

Cancer risks associated with germline mutations in MLH1, MSH2, and MSH6 genes in Lynch syndrome.
Valérie Bonadona, Bernard Bonaïti, Sylviane Olschwang, Sophie Grandjouan, Laetitia Huiart, Michel Longy, Rosine Guimbaud, Bruno Buecher, Yves-Jean Bignon, Olivier Caron,[...]. JAMA 2011
576
33

Implementation of tumor testing for lynch syndrome in endometrial cancers at a large academic medical center.
Jessica Moline, Haider Mahdi, Bin Yang, Charles Biscotti, Andres A Roma, Brandie Heald, Peter G Rose, Chad Michener, Charis Eng. Gynecol Oncol 2013
75
33


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.